MounjaroMenlo Park, CA

Mounjaro in Menlo Park, CA

For Menlo Park, California residents, geographic distance from mainland pharmacies has historically affected access to specialty medications. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly; Pacific-region retail pricing varies by pharmacy. Weight Method offers a separate telehealth program: licensed California providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program is priced at $329/month uniformly, shipped directly to your Menlo Park address.

FDA-approved Mounjaro prescribed by licensed providers. Delivered to your door.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Menlo Park is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated May 2026Medically reviewed by licensed providers

Mounjaro in Menlo Park, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Mounjaro to patients in Menlo Park from $329/month with virtual consultations and direct-to-door shipping.

How does this medication work for weight loss?

Tirzepatide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Eli Lilly developed Mounjaro® as the FDA-approved Injectable pen product, taken Once weekly, approved in 2022. Weight Method is a separate program: licensed providers in California evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program for eligible Menlo Park, CA residents starts at $329/month.

What treatment options are available locally?

Menlo Park's suburban communities are hearing more about GLP-1 treatments through word of mouth and national media. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly since 2022. Weight Method's separate program is straightforward: an online assessment, a virtual provider consultation, and compounded Tirzepatide delivered to your Menlo Park address at $329/month. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.

Ready to Get Started?

Answer a few quick questions to see if you qualify.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

No. Weight Method operates on a direct-pay model with transparent pricing. The compounded Tirzepatide program starts at $329/month and covers your medication, provider consultations, and free delivery to Menlo Park. No insurance claims, no prior authorizations, and no surprise bills. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.

Mounjaro® is a Injectable pen manufactured by Eli Lilly, FDA-approved since 2022 for Type 2 diabetes. It contains Tirzepatide, which mimics natural incretin hormones to reduce appetite, slow gastric emptying, and help your body regulate hunger. Mounjaro® is taken Once weekly. Weight Method does not sell Mounjaro®; we are a separate program that prescribes compounded Tirzepatide (dispensed by a U.S.-licensed 503A pharmacy and not FDA-approved) starting at $329/month.

Yes. Weight Method's licensed providers in California can prescribe compounded Tirzepatide through a fully virtual process. You complete an online health assessment, have a virtual consultation, and if approved, your compounded Tirzepatide is shipped directly to your Menlo Park address. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved. There is no need to visit a physical clinic, and the program starts at $329/month.

Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly. Weight Method prescribes compounded Tirzepatide, which is prepared by a U.S.-licensed 503A compounding pharmacy under state and federal pharmacy regulations. Compounded Tirzepatide is not FDA-approved and is a different regulatory category from FDA-approved finished drug products. Your Weight Method provider will discuss whether compounded Tirzepatide is an appropriate option based on your medical history.

Weight Method's compounded Tirzepatide program starts at $329/month in Menlo Park. That price includes the medication, licensed provider consultations, and free home delivery. We don't bill insurance — there are no copays, no prior authorizations, and no surprise charges. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved. Mounjaro® is a separate FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly; its retail price varies by pharmacy.

Start Your Treatment

Consult with a licensed provider in California and start Mounjaro from $329/month.

Get Started Now

Free consultation. No commitment.

Other Brands in Menlo Park

Ozempic in Menlo ParkWegovy in Menlo ParkZepbound in Menlo ParkRybelsus in Menlo ParkTirzepatide in Menlo Park

Nearby Cities

Mounjaro in Palo Alto, CAMounjaro in Redwood City, CAMounjaro in San Carlos, CAMounjaro in Los Altos, CA

See More

All About MounjaroTirzepatide in Menlo ParkClinics in Menlo Park